These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32657521)

  • 1. Anticancer and antileishmanial in vitro activity of gold(I) complexes with 1,3,4-oxadiazole-2(3H)-thione ligands derived from δ-D-gluconolactone.
    Espinosa AV; Costa DS; Tunes LG; Monte-Neto RLD; Grazul RM; de Almeida MV; Silva H
    Chem Biol Drug Des; 2021 Jan; 97(1):41-50. PubMed ID: 32657521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
    Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
    Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents.
    Waseem D; Butt AF; Haq IU; Bhatti MH; Khan GM
    Daru; 2017 Apr; 25(1):8. PubMed ID: 28376844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
    Bajaj S; Roy PP; Singh J
    Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Variations on the Theme of Gold(III) C
    Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
    Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (C^N
    Williams M; Green AI; Fernandez-Cestau J; Hughes DL; O'Connell MA; Searcey M; Bertrand B; Bochmann M
    Dalton Trans; 2017 Oct; 46(39):13397-13408. PubMed ID: 28945262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 5-(2-hydroxyphenyl)-3-substituted-2,3-dihydro-1,3,4-oxadiazole-2-thione derivatives: promising anticancer agents.
    Aboraia AS; Abdel-Rahman HM; Mahfouz NM; El-Gendy MA
    Bioorg Med Chem; 2006 Feb; 14(4):1236-46. PubMed ID: 16242340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, spectroscopic characterization and in vitro anticancer activity of new platinum(II) complexes with some thione ligands in the presence of triethylphosphine.
    Jomaa MY; Altaf M; Ahmad S; Bhatia G; Singh J; Altuwaijri S; Isab AA
    Biometals; 2017 Oct; 30(5):787-795. PubMed ID: 28986698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dinuclear gold(I) complexes with
    Trevisan G; Vitali V; Tubaro C; Graiff C; Marchenko A; Koidan G; Hurieva AN; Kostyuk A; Mauceri M; Rizzolio F; Accorsi G; Biffis A
    Dalton Trans; 2021 Oct; 50(38):13554-13560. PubMed ID: 34505859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents.
    Taha M; Ismail NH; Imran S; Anouar EH; Selvaraj M; Jamil W; Ali M; Kashif SM; Rahim F; Khan KM; Adenan MI
    Eur J Med Chem; 2017 Jan; 126():1021-1033. PubMed ID: 28012342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting malaria and leishmaniasis: Synthesis and pharmacological evaluation of novel pyrazole-1,3,4-oxadiazole hybrids. Part II.
    Verma G; Khan MF; Mohan Nainwal L; Ishaq M; Akhter M; Bakht A; Anwer T; Afrin F; Islamuddin M; Husain I; Alam MM; Shaquiquzzaman M
    Bioorg Chem; 2019 Aug; 89():102986. PubMed ID: 31146198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes.
    Maftei CV; Fodor E; Jones PG; Freytag M; Franz MH; Kelter G; Fiebig HH; Tamm M; Neda I
    Eur J Med Chem; 2015 Aug; 101():431-41. PubMed ID: 26185007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
    Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
    J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu
    Pettenuzzo N; Brustolin L; Coltri E; Gambalunga A; Chiara F; Trevisan A; Biondi B; Nardon C; Fregona D
    ChemMedChem; 2019 Jun; 14(12):1162-1172. PubMed ID: 31091012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Papaverine Metal Complexes with Potential Anticancer Activities.
    Gaber A; Alsanie WF; Kumar DN; Refat MS; Saied EM
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33233775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A.
    Curran D; Müller-Bunz H; Bär SI; Schobert R; Zhu X; Tacke M
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751607
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies.
    Taha M; Ismail NH; Ali M; Rashid U; Imran S; Uddin N; Khan KM
    Bioorg Chem; 2017 Apr; 71():192-200. PubMed ID: 28228228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer and antitrypanosomal activities of trinuclear ruthenium compounds with orthometalated phenazine ligands.
    da Silva CFN; Chrispim PBH; Possato B; Portapilla GB; Rohrabaugh TN; Ramos LCB; Santana da Silva R; de Albuquerque S; Turro C; Nikolaou S
    Dalton Trans; 2020 Nov; 49(45):16440-16452. PubMed ID: 32776028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.